Successful Management of HFpEF-Related Pulmonary Hypertension With Systemic-Level Pressures Using Sacubitril-Valsartan and Empagliflozin
Sacubitril-valsartan and SGLT2 inhibitors may be effective for treating PH in HFpEF; further investigation is warranted.
Authors
- Geurys Rojas-Marte
- Jennifer Jdaidani
- Mahmoud Shadi (ORCID: https://orcid.org/0000-0002-7423-9773)
- Bahy Abofrekha (ORCID: https://orcid.org/0009-0007-8086-2928)
Institutions
- Deborah Heart and Lung Center (US)
- Staten Island University Hospital (US)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1016/j.jaccas.2025.104827
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00